Manufacturing

Dec 01, 2013
BioPharm International
New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
Nov 26, 2013
By BioPharm International Editors
GlaxoSmithKline plans to invest nearly $41 million to expand its operations at its facility in Montrose, the United Kingdom.
Nov 25, 2013
By BioPharm International Editors
Merck KGaA plans to build a new biomanufacturing facility in Nantong, China.
Nov 15, 2013
By BioPharm International Editors
Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing based biosafety assessments to detect and identify viral contaminants within biologic compounds.
Nov 14, 2013
By BioPharm International Editors
Ei Lilly announces investments in insulin manufacturing capacity for its sites in Indianapolis, Puerto Rico, France, and China.
Nov 12, 2013
By BioPharm International Editors
Schott’s glass vials are specially manufactured to control and reduce delamination potential.
Nov 11, 2013
By BioPharm International Editors
Grifols expands and diversifies portfolio with acquisition of diagnostic business.
Nov 11, 2013
By BioPharm International Editors
Lyra Myers, associate director and value creation agent at Roche, has been elected DCAT president.
Nov 11, 2013
By BioPharm International Editors
AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.
Nov 01, 2013
BioPharm International
The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
native1_300x100
lorem ipsum